Uniprot accession / id : Q8CA95  OR   Uniprot accession / id : Q9Y233
 
Filter by :
Entry Information
Entry status  (1)
REL
(357)
 
Experimental methods  (1)
X-ray diffraction
(357)
 
Authors  (454)
Joseph C
(257)
Rudolph MG
(257)
Kuhn B
(256)
Benz J
(252)
Schlatter D
(252)
Flohr A
(251)
Cole JC
(76)
Kramer C
(76)
Nilly A
(76)
Reutlinger M
(76)
Schaffhauser H
(76)
Tosstorff A
(76)
Groebke-Zbinden K
(60)
Peters J
(28)
Koerner M
(26)
Lerner C
(21)
Brunner M
(20)
Sridhar V
(19)
Badger J
(18)
Bounaud PY
(18)
Chie-Leon B
(18)
Logan C
(18)
Nienaber V
(18)
Recht MI
(18)
Torres FE
(18)
Amano Y
(10)
Chmait S
(10)
Coleman PJ
(10)
Cox CD
(10)
Honbou K
(10)
Hu E
(10)
Masuda N
(10)
Peters JU
(10)
Smith SM
(10)
Yan Y
(10)
Allen JR
(9)
Krasso A
(9)
Renger JJ
(9)
Shipe WD
(9)
Wang H
(9)
Chen N
(8)
Guo L
(8)
Hamaguchi W
(8)
Hou J
(8)
Ke H
(8)
Liu Y
(8)
Liu YD
(8)
Luo HB
(8)
Robinson H
(8)
Rodriguez-Sarmiento RM
(8)
Wang HC
(8)
Zheng M
(8)
Zheng MY
(8)
Chino A
(7)
Davis C
(7)
Huang YY
(7)
Kokubo H
(7)
Kunitomo J
(7)
Li Z
(7)
McGaughey GB
(7)
Mihara T
(7)
Nakashima K
(7)
Oki H
(7)
Porter A
(7)
Taniguchi T
(7)
Tomishima M
(7)
Uslaner JM
(7)
Wu D
(7)
Wu Y
(7)
Yamazaki M
(7)
Yoshikawa M
(7)
Zhao X
(7)
Andrews KL
(6)
Barrow JC
(6)
Bundgaard C
(6)
Christoffersen CT
(6)
Kehler J
(6)
Kilburn JP
(6)
Kunz RK
(6)
Langgard M
(6)
Neidhart W
(6)
Nielsen J
(6)
Ritzen A
(6)
Rogers-Evans M
(6)
Sharik SS
(6)
Theberge CR
(6)
Treanor J
(6)
Zhou Q
(6)
Banner D
(5)
Bissantz C
(5)
Bleicher K
(5)
Brandon NJ
(5)
Brennan J
(5)
Ceccarelli S
(5)
Chen H
(5)
Egerland U
(5)
Erdei J
(5)
Fan KY
(5)
Feigin K
(5)
Fushimi M
(5)
 
More...
 
Homo / hetero assembly  (1)
homo
(357)
 
Assembly composition  (1)
protein structure
(357)
 
Assembly polymer count  (3)
monomer
(344)
trimer
(7)
dimer
(6)
 
Resolution distribution
1.0 - 1.5
(4)
1.5 - 2
(81)
2.0 - 2.5
(237)
2.5 - 3
(33)
3.0 - 3.5
(2)
 
Release year distribution
2005 - 2010
(10)
2010 - 2015
(62)
2015 - 2020
(36)
2020 - 2025
(264)
2025 - 2030
(2)
 
Journal  (14)
To be published
(187)
J Comput Aided Mol Des
(76)
J Med Chem
(26)
Bioorg Med Chem Lett
(18)
J Biomol Screen
(18)
Bioorg Med Chem
(14)
Proc Natl Acad Sci U S A
(8)
ACS Chem Neurosci
(2)
ACS Med Chem Lett
(2)
Chem Pharm Bull (Tokyo)
(2)
ACS Pharmacol Transl Sci
(1)
Acta Crystallogr D Biol Crystallogr
(1)
Acta Pharm Sin B
(1)
J Biol Chem
(1)
 
Macromolecules
Organism superkingdom  (1)
Eukaryota
(357)
 
Organism name  (1)
Homo sapiens
(357)
 
Molecule name  (1)
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
(357)
 
Molecule type  (1)
Protein
(357)
 
Gene names  (1)
PDE10A
(357)
 
Interacting ligands  (361)
ZN : ZINC ION
(335)
MG : MAGNESIUM ION
(327)
GOL : GLYCEROL
(38)
NI : NICKEL (II) ION
(18)
SO4 : SULFATE ION
(10)
PR : PRASEODYMIUM ION
(9)
CL : CHLORIDE ION
(7)
4PX : 3-(1-hydroxy-2-methylpropan-2-yl)-5-phenyl-3,5-dihydro-1H-imidazo[4,5-c][1,8]naphthyridine-2,4-dione
(4)
CMP : ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE
(3)
4LK : 3-[3-fluoranyl-4-[5-methoxy-4-oxidanylidene-3-(2-phenylpyrazol-3-yl)pyridazin-1-yl]phenyl]-1,3-oxazolidin-2-one
(2)
DZU : 8-[(E)-2-[5-methyl-1-[3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]benzimidazol-2-yl]ethenyl]quinoline
(2)
EIK : 5,8-dimethyl-2-[2-(1-methyl-4-phenyl-imidazol-2-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine
(2)
IIR : {(4S)-2-cyclopropyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl}methanol
(2)
JKO : 1-methyl-4-(morpholine-4-carbonyl)-N-[(4R)-2-phenylimidazo[1,2-a]pyridin-7-yl]-1H-pyrazole-5-carboxamide
(2)
PG4 : TETRAETHYLENE GLYCOL
(2)
0CV : 6-methoxy-3,8-dimethyl-4-(piperazin-1-yl)-1H-pyrazolo[3,4-b]quinoline
(1)
0JP : 8,9-dimethoxy-1-(1,3-thiazol-5-yl)-5,6-dihydroimidazo[5,1-a]isoquinoline
(1)
0JQ : 2-{1-[5-(6,7-dimethoxycinnolin-4-yl)-3-methylpyridin-2-yl]piperidin-4-yl}propan-2-ol
(1)
0T6 : 1-(2-chlorophenyl)-6,8-dimethoxy-3-methylimidazo[5,1-c][1,2,4]benzotriazine
(1)
0T7 : 3,4-dimethyl-1-propyl-7-(quinolin-2-ylmethoxy)imidazo[1,5-a]quinoxaline
(1)
15H : (1S)-1-(1-{3-[4-(1,3-benzothiazol-2-ylamino)phenoxy]pyrazin-2-yl}piperidin-4-yl)ethanol
(1)
15J : (1-{3-[4-(1H-benzimidazol-2-ylamino)phenoxy]pyridin-2-yl}piperidin-4-yl)methanol
(1)
1IR : N-[cis-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl]-1,3-benzothiazol-2-amine
(1)
1IS : N-[trans-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl]-1,3-benzothiazol-2-amine
(1)
1XM : 4-amino-1,7-dihydro-6H-pyrazolo[3,4-d]pyrimidine-6-thione
(1)
1XN : 2H-isoindole-1,3-diamine
(1)
2D0 : 4-chloro-1,3-benzothiazol-2-amine
(1)
2F4 : 2-{4-[(6,7-difluoro-1H-benzimidazol-2-yl)amino]phenoxy}-N-methyl-3,4'-bipyridin-2'-amine
(1)
2F5 : 1H-benzimidazol-2-yl(4-{[3-(morpholin-4-yl)pyrazin-2-yl]oxy}phenyl)methanone
(1)
2KR : N-[4-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)phenyl]-5-methylpyridin-2-amine
(1)
2W1 : 1H-benzimidazol-2-yl(4-{[3-(tetrahydro-2H-pyran-4-yl)pyridin-2-yl]oxy}phenyl)methanone
(1)
2ZM : 5-nitro-1H-benzimidazole
(1)
2ZQ : 8-nitroquinoline
(1)
2ZT : 2-[(quinolin-7-yloxy)methyl]quinoline
(1)
2ZU : 2-{[(2-methyl-1,3-benzothiazol-5-yl)oxy]methyl}quinoline
(1)
2ZV : 4-methyl-3-nitropyridin-2-amine
(1)
2ZX : 6-chloropyrimidine-2,4-diamine
(1)
35D : 1-[4-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}quinoxalin-2-yl)piperidin-1-yl]ethanone
(1)
35E : [1-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}pyrazin-2-yl)piperidin-4-yl]methanol
(1)
35G : GUANOSINE-3',5'-MONOPHOSPHATE
(1)
3A6 : 3-AMINO-6-FLUORO-2-[4-(2-METHYLPYRIDIN-4-YL)PHENYL]-N-(METHYLSULFONYL)QUINOLINE-4-CARBOXAMIDE
(1)
3K9 : 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one
(1)
3KB : 5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-1-[3-(trifluoromethyl)phenyl]pyridazin-4(1H)-one
(1)
3KG : 3-(1-phenyl-1H-pyrazol-5-yl)-1-[3-(trifluoromethyl)phenyl]pyridazin-4(1H)-one
(1)
3SJ : 1-methyl-5-(1-methyl-3-{[4-(quinolin-2-yl)phenoxy]methyl}-1H-pyrazol-4-yl)pyridin-2(1H)-one
(1)
490 : 1-methyl-5-(1-methyl-3-{[4-(1-methyl-1H-benzimidazol-4-yl)phenoxy]methyl}-1H-pyrazol-4-yl)pyridin-2(1H)-one
(1)
4F7 : 2-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]quinoxaline
(1)
4GK : 2-[2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-3-methyl-3H-imidazo[4,5-f]quinoline
(1)
4HN : 2-(2'-ETHOXYBIPHENYL-4-YL)-4-HYDROXY-1,6-NAPHTHYRIDINE-3-CARBONITRILE
(1)
4LP : 1-(cyclopropylmethyl)-4-fluoranyl-5-[5-methoxy-4-oxidanylidene-3-(2-phenylpyrazol-3-yl)pyridazin-1-yl]-3,3-dimethyl-indol-2-one
(1)
4Q0 : 2-{2-[3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}-4-(propan-2-yloxy)-1H-isoindole-1,3(2H)-dione
(1)
4XS : 4,6-dichloro-2-cyclopropyl-5-methylpyrimidine
(1)
4XU : 6-chloro-N-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-5-methyl-2-[3-(quinolin-2-yl)propoxy]pyrimidin-4-amine
(1)
4XV : 6-chloro-2-cyclopropyl-5-methylpyrimidin-4-amine
(1)
4XY : 6-chloro-2-cyclopropyl-5-methyl-N-propylpyrimidin-4-amine
(1)
4Y1 : 6-chloro-N-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-5-methyl-2-[2-(pyridin-2-yl)ethoxy]pyrimidin-4-amine
(1)
4Y2 : 6-chloro-2-cyclopropyl-N-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-5-methylpyrimidin-4-amine
(1)
4ZE : 4-amino-2-methylphenol
(1)
540 : 8-fluoro-6-methoxy-3,4-dimethyl-1-(3-methylpyridin-4-yl)imidazo[1,5-a]quinoxaline
(1)
546 : 2-methoxy-6,7-dimethyl-9-(4-methylpyridin-3-yl)imidazo[1,5-a]pyrido[3,2-e]pyrazine
(1)
548 : 6-chloro-3,4-dimethyl-1-(3-methylpyridin-4-yl)-8-(trifluoromethyl)imidazo[1,5-a]quinoxaline
(1)
5AV : 5-chloro-N-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine
(1)
5AY : N-[(1-methyl-1H-pyrazol-4-yl)methyl]-5-{[(1S,2S)-2-(pyridin-2-yl)cyclopropyl]methoxy}pyrazolo[1,5-a]pyrimidin-7-amine
(1)
5GP : GUANOSINE-5'-MONOPHOSPHATE
(1)
5M6 : 1-(4-chlorophenyl)-3-methyl-~{N}-[[(2~{R})-oxolan-2-yl]methyl]thieno[2,3-c]pyrazole-5-carboxamide
(1)
5M9 : 6-chloranyl-5,8-dimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyridine
(1)
5MF : 8-ethyl-5-methyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine
(1)
5MG : 3-(2-chloranyl-5-phenyl-1~{H}-imidazol-4-yl)-1-[3-(trifluoromethyloxy)phenyl]pyridazin-4-one
(1)
5NI : 5-NITROINDAZOLE
(1)
5ZE : 4,6-dimethylpyrimidin-2-amine
(1)
67A : 3-(1-phenyl-1H-pyrazol-5-yl)-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one
(1)
6DT : N-(4-((5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy)phenyl)-1H-benzimidazol-2-amine
(1)
6DW : 1-(cyclopropylmethyl)-5-(2-(2,3-dihydro-1H-imidazo[1,2-a]benzimidazol-1-yl)ethoxy)-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one
(1)
6RC : 4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]-2-(quinolin-2-yloxymethyl)imidazo[1,2-a]pyrazin-8-yl]morpholine
(1)
7ZE : 5-nitroquinoline
(1)
8G3 : 2-methyl-5-[2-([1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-ol
(1)
8G6 : 7-(4-chlorophenyl)-2-methyl-pyrazolo[1,5-a]pyrimidine
(1)
8Q7 : 9-[(1S)-2,2-difluorocyclopropane-1-carbonyl]-6-[(4-methoxyphenyl)methyl]-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one
(1)
8ZE : 2,3-dihydro-1,4-benzodioxin-6-ylmethanol
(1)
9G6 : N-[2-(7-methoxy-4-morpholin-4-yl-quinazolin-6-yl)oxyethyl]-1,3-benzothiazol-2-amine
(1)
9ZE : 1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone
(1)
A1L31 : ~{N}-(2-azanyl-2-sulfanylidene-ethyl)-2-[3-[3-(dimethylcarbamoyl)-6-fluoranyl-imidazo[1,2-a]pyridin-2-yl]azetidin-1-yl]quinoline-4-carboxamide
(1)
A1LWO : 2,6-diazaspiro[3.3]heptan-2-yl-[2-[[4-[5-(2-methylpyridin-4-yl)-3-(trifluoromethyl)pyrazol-1-yl]phenoxy]methyl]quinolin-4-yl]methanone
(1)
AEL : 2-{2-[5-methyl-1-(pyridin-4-yl)-1H-benzimidazol-2-yl]ethyl}-1H-benzo[de]isoquinoline-1,3(2H)-dione
(1)
AEO : 2-[2-(4-phenyl-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)ethyl]-1H-benzo[de]isoquinoline-1,3(2H)-dione
(1)
AMP : ADENOSINE MONOPHOSPHATE
(1)
AXC : 5-(1H-BENZIMIDAZOL-2-YLMETHYLSULFANYL)-2-METHYL-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLINE
(1)
BR : BROMIDE ION
(1)
C1L : 6-methoxy-3,8-dimethyl-4-(morpholin-4-ylmethyl)-1H-pyrazolo[3,4-b]quinoline
(1)
D6X : N-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]quinolin-2-amine
(1)
D79 : 4-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]-3,7,8,10-tetrazatricyclo[7.4.0.0^{2,7}]trideca-1,3,5,8,10,12-hexaen-6-ol
(1)
D7C : 2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-1-[(2S)-2-methyl-1,2-dihydroimidazo[1,2-a]benzimidazol-3-yl]ethanone
(1)
DKU : 3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one
(1)
DL0 : 6-chloranyl-3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one
(1)
EDO : 1,2-ETHANEDIOL
(1)
EEI : 5,7-dimethyl-2-[(1-methyl-4-phenyl-imidazol-2-yl)sulfanylmethyl]imidazo[1,2-a]pyrimidine
(1)
EFJ : 2-(1~{H}-benzimidazol-2-ylsulfanylmethyl)-3-bromanyl-5,7-dimethyl-imidazo[1,2-a]pyrimidine
(1)
EHI : 8-methyl-2-[2-(1-methyl-4-phenyl-imidazol-2-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyridine
(1)
EIH : 2-[(1-methyl-4-phenyl-imidazol-2-yl)methylsulfanyl]-[1,2,4]triazolo[1,5-a]pyridine
(1)
EV1 : 1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXYISOQUINOLINE
(1)
 
More...
 
Function and Biology
EC number / name  (1)
3.1.4.17 : 3',5'-cyclic-nucleotide phosphodiesterase
(357)
 
Biological function  (2)
3',5'-cyclic-nucleotide phosphodiesterase activity
(354)
phosphoric diester hydrolase activity
(354)
 
Biological process  (1)
signal transduction
(354)
 
Sequence and Structure classification
CATH class  (2)
Mainly Alpha
(89)
Alpha Beta
(1)
 
CATH topology  (2)
Catalytic domain of cyclic nucleotide phosphodiesterase 4b2b
(89)
Beta-Lactamase
(1)
 
Pfam accession / name  (1)
PF00233 : PDEase_I
(1)
 
Experimental Information
Diffraction protocol  (2)
Single wavelength
(356)
MAD
(1)
 
Diffraction radiation source type  (3)
Synchrotron
(324)
Rotating anode
(26)
Sealed tube
(7)
 
Diffraction source  (28)
SLS BEAMLINE X10SA
(257)
APS BEAMLINE 22-ID
(17)
NSLS BEAMLINE X29A
(8)
RIGAKU FR-E SUPERBRIGHT
(8)
RIGAKU MICROMAX-007 HF
(8)
PHOTON FACTORY BEAMLINE AR-NE3A
(7)
ALS BEAMLINE 5.0.3
(6)
CLSI BEAMLINE 08ID-1
(6)
ALS BEAMLINE 5.0.2
(5)
APS BEAMLINE 17-ID
(5)
OXFORD DIFFRACTION NOVA
(4)
OXFORD DIFFRACTION ENHANCE ULTRA
(3)
RIGAKU
(3)
RIGAKU FR-E+ SUPERBRIGHT
(3)
APS BEAMLINE 17-BM
(2)
APS BEAMLINE 24-ID-C
(2)
RIGAKU FR-E
(2)
ALS BEAMLINE 5.0.1
(1)
APS BEAMLINE 21-ID-F
(1)
APS BEAMLINE 22-BM
(1)
ESRF BEAMLINE ID14-4
(1)
ESRF BEAMLINE ID23-1
(1)
ESRF BEAMLINE ID29
(1)
RIGAKU MICROMAX-007
(1)
RIGAKU RU300
(1)
SPRING-8 BEAMLINE BL26B2
(1)
SPRING-8 BEAMLINE BL41XU
(1)
SSRL BEAMLINE BL14-1
(1)
 
Synchrotron site  (9)
SLS
(257)
APS
(28)
ALS
(12)
NSLS
(8)
Photon Factory
(7)
CLSI
(6)
ESRF
(3)
SPring-8
(2)
SSRL
(1)
 
Representative Structures
Representative Structures
100%
95%
90%
70%
50%
40%
30%
...
Entries 1 to 10 of 357
Entries 1 to 10 of 357
 Select all entries on this page
Crystal structure of the catalytic domain of human PDE10A complexed with (2-((4-(5-(2-methylpyridin-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenoxy)methyl)quinolin-4-yl)(2,6-diazaspiro[3.3]heptan-2-yl)methanone
Zhang FC, Huang YY, Luo HB, Guo L
To be published
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: MG    ZN    ZN    MG    A1LWO   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
2.3Å resolution
Released: 15 Jan 2025
Model geometry
Fit model/data
8xv3
8xv3
8xv3
Crystal structure of PDE10A catalytic domain complexed with LHB-6
Li Z, Huang Y, Zhan CG, Luo HB
J Med Chem (2019) [PMID: 30689375  ]
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: MG    ZN    9G6    ZN    MG   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
2.8Å resolution
Released: 20 Feb 2019
Model geometry
Fit model/data
5znl
5znl
5znl
PDE10a with imidazopyrazine inhibitor
Gibbs AG, Schubert C
Bioorg Med Chem Lett (2016) [PMID: 27491708  ]
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: MG    ZN    ZN    MG    6RC   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
2.7Å resolution
Released: 24 Aug 2016
Model geometry
Fit model/data
5k9r
5k9r
5k9r
Crystal Structure of human phosphodiesterase 10 in complex with 6,8-dichloro-2-[2-(6,7-dimethyl-1H-benzimidazol-2-yl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyridine
Joseph C, Benz J, Flohr A, Lerner C, Rudolph MG
To be published
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: K7O    MG    ZN    K7O    ZN    MG   
Modified residues: CME    CME   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
2.05Å resolution
Released: 12 Oct 2022
Model geometry
Fit model/data
5sjn
5sjn
5sjn
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c13c(cc2c(c1)CCN2)[nH]c(n3)SCc4ncc(c(c4C)OC)C, micromolar IC50=0.2659405
Joseph C, Benz J, Flohr A, Krasso A, Rudolph MG
To be published
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: JIY    MG    ZN    JIY    ZN    MG   
Modified residues: CME    CME   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
1.98Å resolution
Released: 12 Oct 2022
Model geometry
Fit model/data
5shu
5shu
5shu
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH n2(c(c(C(N1CCC1)=O)cn2)C(Nc4nn(C3CCCC3)cc4)=O)C, micromolar IC50=0.075252
Joseph C, Peters JU, Benz J, Schlatter D, Rudolph MG
J Comput Aided Mol Des (2022) [PMID: 36153472  ]
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: MG    ZN    IQ9    ZN    IQ9    MG   
Modified residues: CME    CME   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
2.41Å resolution
Released: 12 Oct 2022
Model geometry
Fit model/data
5sfv
5sfv
5sfv
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c1(cccc(n1)CCc2nc(cn2C)c3ccccc3)N4CCOCC4, micromolar IC50=3.142777
Joseph C, Groebke-Zbinden K, Benz J, Schlatter D, Rudolph MG
J Comput Aided Mol Des (2022) [PMID: 36153472  ]
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: MG    ZN    IAY    IAY    ZN    MG   
Modified residues: CME    CME   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
2.19Å resolution
Released: 12 Oct 2022
Model geometry
Fit model/data
5sdx
5sdx
5sdx
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH C1=CN(N=C(C1=O)c2ccnn2c3cc(ccc3F)F)c4cc(ccc4)OC(F)(F)F, micromolar IC50=0.047063
Joseph C, Benz J, Flohr A, Rogers-Evans M, Rudolph MG
To be published
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: KER    MG    PR    GOL    ZN    PR    ZN    MG    KER   
Modified residues: CME    CME   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
2.3Å resolution
Released: 12 Oct 2022
Model geometry
Fit model/data
5skd
5skd
5skd
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c1(ncnc(c1)C)Nc2ccc(C)cc2, micromolar IC50=408.404817
Joseph C, Benz J, Flohr A, Beresini M, Rudolph MG
To be published
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: MG    ZN    JSY    ZN    MG    JSY   
Modified residues: CME    CME   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
1.99Å resolution
Released: 12 Oct 2022
Model geometry
Fit model/data
5sit
5sit
5sit
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c12c(cccc1)nc(n2C)CCN4CCOc3ccccc3C4=O, micromolar IC50=2.844764
Joseph C, Benz J, Flohr A, Koerner M, Rudolph MG
To be published
Source organism: Homo sapiens  
Assembly composition: protein only structure
Bound ligands: MG    ZN    J7M    J7M    ZN    MG   
Modified residues: CME    CME   
Assembly name: cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Preferred)   search this complex
PDBe complex ID: PDB-CPX-195088 (Preferred)   search this ID
PDBe-KB: Q9Y233   
X-ray diffraction
1.98Å resolution
Released: 12 Oct 2022
Model geometry
Fit model/data
5sh6
5sh6
5sh6
...
Entries 1 to 10 of 357
Entries 1 to 10 of 357